Last reviewed · How we verify

NCT07297966

Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Young Children

Recruiting now Phase 2 Last updated 17 April 2026
What this trial tests

Phase 2 trial testing Probiotic in Recurrent Respiratory Tract Infections in 120 participants. Currently enrolling.

Timeline
14 May 2025
Primary endpoint
30 June 2026
30 June 2026

Quick facts

Lead sponsorMin-Tze LIONG
PhasePhase 2
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment120
Start date14 May 2025
Primary completion30 June 2026
Estimated completion30 June 2026
Sites2 locations across China, Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

Min-Tze LIONG

Who can join

Adults 1 Day to 6, any sex, with Recurrent Respiratory Tract Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is an 8-weeks, randomized controlled trial involving children under 6 years of age who meet clinical diagnostic criteria for RRTI. Participants are randomized to receive either probiotic or placebo. The primary clinical outcomes assessed are duration and frequency of respiratory symptoms and quality of life. To investigate potential mechanisms, stool samples were collected pre- and post-intervention for metagenomics gene sequencing to analyze changes in gut microbiota composition and identify specific bacterial taxa associated with clinical improvements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Probiotic

Trials testing the same drug.

Other recruiting trials for Recurrent Respiratory Tract Infections

Currently open trials in the same condition.

Other Min-Tze LIONG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07297966.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing